Aclaris Therapeutics, Inc. (ACRS)

NASDAQ: ACRS · Real-Time Price · USD

3.790

+0.040 (1.07%)

At close: Oct 26, 2026, 4:00 PM EDT

3.840

+0.050 (1.32%)

Pre-market: Oct 27, 2026, 5:20 AM EDT

Aclaris Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	8.22	7.83	18.72	31.25	29.5	6.64
Other Revenue	-	-	-	-	0.26	0.12
Revenue	8.22	7.83	18.72	31.25	29.75	6.76
Revenue Growth	-51.04%	-58.19%	-40.09%	5.03%	340.05%	4.30%
Cost of Revenue	70.49	59.93	49.04	114.25	89.77	48.53
Gross Profit	-62.28	-52.1	-30.32	-83	-60.02	-41.77
Selling, General & Admin	23.24	21.97	22.2	31.51	25.13	23.62
Operating Expenses	23.24	21.97	22.2	31.51	25.13	23.62
Operating Income	-85.51	-74.08	-52.53	-114.51	-85.15	-65.38
Interest & Investment Income	6.73	7.64	7.95	8.51	-	-
Other Non Operating Income (Expenses)	3.85	3.82	1.91	-	2.95	-1.14
EBT Excluding Unusual Items	-74.94	-62.62	-42.66	-106	-82.21	-66.53
Merger & Restructuring Charges	-	-	-	-3.12	-	-
Other Unusual Items	-0.8	-2.3	-2.5	26.9	-4.7	-24.34
Pretax Income	-75.74	-64.92	-132.07	-88.85	-86.91	-90.87
Income Tax Expense	-	-	-	-0.37	-	-
Earnings From Continuing Operations	-75.74	-64.92	-132.07	-88.48	-86.91	-90.87
Net Income	-75.74	-64.92	-132.07	-88.48	-86.91	-90.87
Net Income to Common	-75.74	-64.92	-132.07	-88.48	-86.91	-90.87
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	129	123	77	70	65	57
Shares Outstanding (Diluted)	129	123	77	70	65	57
Shares Change	25.53%	58.56%	10.73%	7.05%	14.95%	33.36%
EPS (Basic)	-0.59	-0.53	-1.71	-1.27	-1.33	-1.60
EPS (Diluted)	-0.59	-0.53	-1.71	-1.27	-1.33	-1.60
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-62.18	-47.22	-20.2	-79.63	-68.17	-52.44
Free Cash Flow Per Share	-0.48	-0.39	-0.26	-1.14	-1.04	-0.92
Gross Margin	-	-	-161.99%	-265.60%	-201.74%	-
Operating Margin	-1040.43%	-946.52%	-280.59%	-366.44%	-286.21%	-967.08%
Profit Margin	-921.50%	-829.58%	-705.48%	-283.15%	-292.11%	-1343.96%
Free Cash Flow Margin	-756.50%	-603.42%	-107.89%	-254.84%	-229.13%	-775.65%
EBITDA	-85.53	-74.04	-52.22	-114.45	-	-65.06
EBITDA Margin	-	-	-278.95%	-	-	-
D&A For EBITDA	-0.01	0.04	0.31	0.06	-	0.32
EBIT	-85.51	-74.08	-52.53	-114.51	-85.15	-65.38
EBIT Margin	-	-	-280.59%	-	-286.21%	-
Revenue as Reported	8.22	7.83	18.72	31.25	29.75	6.76

SEC Filings: 10-K · 10-Q